Physician profile
Alan Zend
NPI 1215905245
$889.18
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $604 · 2020: $68.17 · 2021: $117 · 2022: $60.53 · 2023: $20.88 · 2024: $18.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $39.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $39.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $148.74 | 2019 | |
| Indivior INC. | $140.35 | 2019-2021 | |
| Orexo US, INC. | $119.82 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $109.47 | 2019-2022 | |
| Mdd US Operations, LLC | $94.28 | 2019 | |
| Lilly USA, LLC | $93.11 | 2019-2024 | Mounjaro |
| Novo Nordisk INC | $85.05 | 2019-2021 | |
| Allergan, INC. | $55.43 | 2019-2020 | |
| Virtus Pharmaceuticals LLC | $24.98 | 2021 | |
| Zyla Life Sciences, INC. | $17.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Zend listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.